Logout Login Cart iconShop
Contact Sales

Search

Filters

Content Type

Products

Clear Filters

Search Results for "fc coins satin al Visit Buyfc26coins.com for latest FC 26 coins news..XeZ3"

Looking for quality documents?
news icon
Repligen Appoints Maggie A. Pax to Board of Directors
news icon
Repligen Announces Publication of the Company’s 2022 Sustainability Report
news icon
Repligen Corporation to Present at Upcoming Investor Conferences
news icon
Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova
news icon
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
news icon
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
news icon
Repligen Expands Process Analytics Portfolio with DRS Daylight Solutions Agreement.
news icon
UPDATE – Repligen Announces Publication of the Company’s 2022 Sustainability Report
news icon
Repligen completes the acquisition of Metenova
Repligen acquired Metenova, a leading Swedish innovator in magnetic mixing technology for biopharmaceutical production. This strategic step further strengthens Repligen's Fluid Management franchise, enriching our single-use mixing solutions and expanding our product range. Welcome, Metenova!
external link icon
Repligen Reports Third Quarter 2013 Financial Results
- Product Revenue Grows 10% for the Quarter - - Net Income Grows 226% to $5.9 Million - - Earnings Conference Call and Webcast Today at 9:00 a.m. EST - WALTHAM, Mass., Nov. 7, 2013 (GLOBE NEWSWIRE) - Repligen Corporation (Nasdaq:RGEN) today reported financial results for the third quarter ended September 30, 2013. Below are the Company's financial and business highlights for the third quarter, financial guidance for the year and dial-in numbers for today's conference call. Third Quarter 2013 Financial Highlights Bioprocessing product revenue for the third quarter of 2013 was $12.2 million, an increase of approximately10% over the third quarter of 2012.
  Total revenue for the third quarter of 2013 was $18.8 million, an increase of approximately 25% over the third quarter of 2012.
  Bioprocessing product gross profit margin was 53.5% for the third quarter of 2013, compared to 42.3% during the third quarter of 2012.
  Net income increased to $5.9 million
Close modal

A new look. A better way to explore Repligen.

We’ve redesigned Repligen.com to help you find the right solutions faster, with greater clarity and less effort.

Find what you need faster
Get to the right information with quicker site speed

Explore the site with ease
Navigate easily with an intuitive, simple site structure

Access product details instantly
Find products and resources faster, in fewer clicks

Get support when you need it
Connect with our team when you need support